C
Catalyst Pharmaceuticals, Inc. (CPRX)
NCM – Real Time Price. Currency in USD
31.50
+0.08 (0.25%)
At close: Jun 26, 2026, 4:00 PM EDT
31.39
-0.11 (-0.35%)
After-hours: Jun 26, 2026, 7:54 PM EDT
Find any stock by ticker or company name

NCM – Real Time Price. Currency in USD
31.50
+0.08 (0.25%)
At close: Jun 26, 2026, 4:00 PM EDT
31.39
-0.11 (-0.35%)
After-hours: Jun 26, 2026, 7:54 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 7.10 | 6.05 | 10 | |
| Quick ratio | 6.84 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 10 | |
| Weighted average score | 10 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 214M | 398M | 492M | 589M | 597M |
| Gross Profit | 180M | 314M | 386M | 464M | 475M |
| Operating Income | 102M | 87M | 195M | 258M | 268M |
| Net Income | 83M | 71M | 164M | 214M | 221M |
| EBITDA | 103M | 120M | 233M | 296M | 306M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 6.31 | 17.07 | 7.0 |
| Next quarter | 9.01 | 15.87 | 7.5 |
| Current year | 7.87 | 16.27 | 7.5 |
| Next year | 13.03 | 23.21 | 9.0 |
| Weighted average score | 7.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -2.1 | 20.94 | 21.95 | 32.77 | 7.8 |
| Y/Y | 5.63 | 12.33 | 11.11 | -0.79 | 5.0 |
| 3y average | 43.06 | 48.75 | 40.06 | 125.16 | 10 |
| 5y average | 39.91 | 41.86 | 35 | 100.56 | 10 |
| Weighted average score | 8.2 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $755.9M significantly exceed its total debt $2.7M, ensuring strong financial flexibility
Total current assets $940.4M exceed Total current liabilities $132.4M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength
The company generates positive free cash flow $59.6M, supporting its financial health